Disruptive
Behavior Disorder (DBD) Medication Market by Disease Type (Oppositional
Defiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), by
Medication Type (Stimulant, Antipsychotics, Alpha-Agonist, Anticonvulsant, and
Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and
Online Pharmacy), and by Geography (North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity
Analysis, 2018 – 2026
Disruptive behavior disorder
comprises a group of disorders including oppositional defiant disorder, conduct
disorder, and intermittent explosive disorder. It usually affects young people
below 18 years of age. Children/teenagers suffering from this disorder are
unable to regulate her/his emotions and behaviors, act defiant, and are in
conflict with other peers in surrounding thereby facing low quality of life at
home, school, or both. Various causes of DBD include child abuse or neglect, a
traumatic life experience, such as sexual abuse or violence, and a family
history of DBDs. DBDs can be treated with variety of option, initiated with
psychological therapy. Under psychological therapy, counselling and guidance is
provided either to parent or child alone, or family together, to improve
response to incidence of DBDs. Medication treatment is preferred either in
combination with psychological treatment or started when psychological therapy
proves to be insufficient.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2390
Disruptive Behavior Disorder Medication
Market - Market Dynamics
Major factors responsible for
growth of the disruptive behavior disorder medication market are rising burden
of the disruptive behavior disorders worldwide, increasing awareness amongst
parent about this disorder, and improvement of psychotic and medication
treatment. According to a study published in the journal BMJ Open (Matthew D
Burkey et al) in 2015, oppositional defiant disorder (ODD) and conduct disorder
(CD) had an estimated worldwide prevalence of 3.3% and 3.2%, respectively.
World Health Organization in its 2016 factsheet stated that globally, 7.4 % of
disability-adjusted life years (DALYs) are caused by disorders in mental and
behavioral disorders category.
Disruptive Behavior Disorder
Medication Market - Regional Insights
On the basis of geography,
disruptive behavior disorder medication market is segmented into North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is
expected to be the leading region in the disruptive behavior disorder
medication market during forecast period. According to statistics given by
Agency for Healthcare Research and Quality in 2016, 3 out of every 100 children
in the U.S. are affected by disruptive behavior disorder, it affects more
number of boys than girls and is common among children aged 12 years and older.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/disruptive-behavior-disorder-dbd-medication-market-2390
‘Speak Up for Kids’ campaign is
an education and outreach initiatives by Child Mind Institute (U.S. based
non-profit organization), through which awareness about mental health issues
and needed information is provided to families, educators, the media, and
policymakers. Various medical centers and hospitals such as Arkansas Valley
Behavioral Health System have established dedicated resources for treatment of
disruptive behavior disorder.
Disruptive Behavior Disorder
Medication Market - Competitive Landscape
Key players present in the
disruptive behavior disorder medication market are Promius Pharma LLC, Shire
PLC, Johnson and Johnson, Mylan N.V., Novartis AG, Teva Pharmaceuticals
Industries Ltd., GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Lupin
Ltd., and Eli Lilly and Company.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2390
About Coherent
Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
No comments:
Post a Comment